Showing results (481-490 of 538) with videos related to

Sort By:
Pageof 54
Headache|April 13, 2019
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical TrialsStephen D Silberstein, Peter McAllister, Xiaoping Ning, et al.
Intensive Care Medicine|June 11, 2009
Circulating levels of vasoactive peptides in patients with acute bacterial meningitisRonan M G Berg, Gitte Irene Strauss, Flemming Tofteng, et al.
Neurology|August 10, 2014
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine preventionTony W Ho, Kathryn M Connor, Ying Zhang, et al.
Headache|May 22, 2010
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical programDavid W Dodick, Catherine C Turkel, Ronald E DeGryse, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
The Journal of Pain|December 3, 2014
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an exampleDavid W Dodick, Catherine C Turkel, Ronald E DeGryse, et al.
Headache|December 6, 2005
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trialStephen D Silberstein, Frederick G Freitag, Todd D Rozen, et al.
Headache|August 20, 2005
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trialJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
The Journal of Headache and Pain|December 20, 2005
The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE)Paolo Martelletti, Redda T Haimanot, Miguel J A Láinez, et al.
Cephalalgia : an International Journal of Headache|September 22, 2010
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteriesLars Edvinsson, Kayi Y Chan, Sajedeh Eftekhari, et al.
Pageof 54